810-1140 W.Pender St
Member Sector: Biopharmaceuticals
Celator Technologies Inc. is a private biopharmaceutical company developing new carrier technology for targeting combinations of rationally selected chemotherapeutic agents to sites of disease. Currently, the company is focused on cancer and is utilizing established drugs selected for synergistic activity in rapid, cell-based screening assays. Celator is designing products to be active against major tumor populations such as lung, colorectal, advanced breast, and ovarian cancer.